β2-chimaerin has been proposed to influence cytoskeleton-mediated processes in different cell types by inhibiting Rac activity [15, 22, 27, 28], but these functions are only poorly characterized in breast cancer epithelial cells. This evidence concerns the gene AKT1 and breast cancer.